Coloplast has now settled most of its mesh suits

Medical device company Coloplast is about to close the chapter on the plethora of lawsuits the company has been met with since 2013 due to its faulty transvaginal mesh products. 95 percent of the cases have been settled, the company said in its interim report.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Reuters: Kinesere vil købe J&J's diabetesforretning

Amerikanske Johnson & Johnson kan være på vej til at sælge sin forretning for diabetesudstyr for godt 24 mia. kr., efter flere kinesiske aktører ifølge Reuters har vist interesse i at overtage forretningsdelen.

Related articles